N

Northwest Research Center | Portland, OR

Research site
(Unclaimed)
Location
6327 SE Milwaukie Avenue, 2nd Floor, Portland, Oregon, United States of America
Site insights

Top conditions

Rhinitis (2 trials)

Cough (2 trials)

Allergic Rhinitis (2 trials)

Obesity (1 trial)

Perennial Allergic Rhinitis (1 trial)

Top treatments

AD109
LY3502970
EDP-938
Orforglipron
LY3454738
Lebrikizumab
S-600918
ADX-629
OPN-375

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 11
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma

This is a US study comparing the efficacy and safety of BDA MDI [Budesonide/Albuterol Sulfate (BDA) metered dose inhaler (MDI)] with AS [Albuterol Su...

Active, not recruiting
Asthma
Drug: BDA MDI
Drug: AS MDI

The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabete...

Enrolling
Chronic Kidney Disease
Overweight
Drug: Orforglipron
Drug: Insulin Glargine

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perennial allergic rhinitis. The stu...

Not yet enrolling
Perennial Allergic Rhinitis (PAR)
Drug: Placebo
Drug: Standard therapy for INCS

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Obs...

Enrolling
OSA
Drug: Placebo
Drug: AD109

Trial sponsors

Lilly logo

Lilly (3 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems